@article{ddfb6f6517b046df9559e86b78753b18,
title = "SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19 (Protocol)",
abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effectiveness and safety of SARS-CoV-2-neutralising mAbs, including mAb fragments, to prevent infection with SARS-CoV-2 causing COVID-19; and to maintain the currency of the evidence, using a living systematic review approach.",
author = "Caroline Hirsch and Valk, \{Sarah J.\} and Vanessa Piechotta and Chai, \{Khai Li\} and Estcourt, \{Lise J.\} and Ina Monsef and Susanne Salomon and Eve Tomlinson and Maria Popp and Wood, \{Erica M.\} and Cynthia So-Osman and Roberts, \{David J.\} and Zoe McQuilten and Nicole Skoetz and Nina Kreuzberger",
note = "Funding Information: The research was part of a project supported by the German Federal Ministry of Education and Research (NaFoUniMedCovid19, funding number: 01KX2021; part of the projects 'COVIM' and 'CEOsys'). The contents of this document reflect only the authors' views and the German Ministry is not responsible for any use that may be made of the information it contains. Funding Information: The research was supported by NHS Blood and Transplant and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Funding Information: SS: is funded by the Federal Ministry of Education and Research, Germany (NaFoUniMedCovid19, funding number: 01KX2021; part of the project {"}COVIM{"}, which was paid to the institution). I have participated in a study on kinetics of the neutralising antibody response to SARS-CoV-2 (www.biorxiv.org/content/10.1101/2021.01.26.428207v1). In this review, I will not be involved in risk of bias assessment, data extraction or interpretation, but will serve as content expert. Funding Information: NK: is funded by the Federal Ministry of Education and Research, Germany (NaFoUniMedCovid19, funding number: 01KX2021; part of the project {"}COVIM{"}, which was paid to the institution). Funding Information: The CEOsys project is funded under a scheme issued by the Network of University Medicine (Nationales Forschungsnetzwerk der Universit{\"a}tsmedizin (NUM)) by the Federal Ministry of Education and Research of Germany (Bundesministerium f{\"u}r Bildung und Forschung (BMBF)) Publisher Copyright: Copyright {\textcopyright} 2021 The Cochrane Collaboration. Published by John Wiley \& Sons, Ltd. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = may,
day = "20",
doi = "10.1002/14651858.CD014945",
language = "English",
volume = "2021",
journal = "Cochrane Database of Systematic Reviews",
issn = "1469-493X",
publisher = "John Wiley \& Sons",
number = "5",
}